Moberg Pharma
Moberg Pharma granted U.S. patent relating to improved dosing of MOB-015
Moberg Pharma AB (OMX: MOB) today announced that the United States Patent and Trademark Office (USPTO) has granted a patent relating to an improved…
Company newsroom
1 releases
Moberg Pharma AB (OMX: MOB) today announced that the United States Patent and Trademark Office (USPTO) has granted a patent relating to an improved…